119-hr-747119th Congress

Stop Chinese Fentanyl Act of 2025

Sponsored By: Representative Barr, Andy [R-KY-6]

Passed House

Summary

Targets Chinese fentanyl production and supply chains with expanded sanctions and accountability. The bill would broaden who can be designated for sanctions, press the Chinese government to tighten chemical controls, and add new review rules for U.S. emergency economic authorities while excluding ordinary goods imports.

Show full summary
  • Chinese entities and senior officials: It would widen the definition of a "foreign opioid trafficker" to cover any foreign person and explicitly include Chinese entities that produce or move fentanyl or precursors if they fail to take credible steps to stop trafficking. It adds the heads of four Chinese agencies to designation considerations and extends designation periods from 5 to 10 years.
  • U.S. executive branch and Congress: When emergency powers are used for international drug trafficking the President must provide annual written evaluations to specified congressional committees. The President must also weigh costs and benefits, set termination criteria, and explain how any regulations will resolve the emergency.
  • Trade and chemical controls: The bill expresses congressional urging that China adopt know‑your‑customer rules, proper labeling, and controls on unregulated precursor chemicals. It also specifies that the Act may not be used to sanction the importation of goods, with "goods" defined to exclude technical data.

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Bill Overview

Analyzed Economic Effects

4 provisions identified: 2 benefits, 0 costs, 2 mixed.

Ban on sanctions for imported goods

If enacted, the Act would forbid using its authorities to impose sanctions on the importation of goods. The bill defines 'goods' to include products, materials, supplies, manufactured items, and inspection or test equipment, and to exclude technical data. This change would take effect upon enactment and could reduce the risk of trade disruptions for businesses and consumers.

Allow sanctioning Chinese companies and officials

If enacted, the bill would let the President label Chinese companies as foreign opioid traffickers if they make, sell, finance, or ship fentanyl or its precursors and fail to use credible checks like know-your-customer procedures. It would also let the President designate senior Chinese officials who oversee those companies and who aid or ignore trafficking. The heads of several named Chinese agencies would be considered when making these designations. These changes would take effect upon enactment.

Yearly review of emergency sanctions

If enacted, the President would have to send Congress a written evaluation at least once a year when using certain emergency economic powers for international drug trafficking. The report must assess effectiveness, include public- and private-sector views, and propose possible changes. Regulations made under those powers would need cost-benefit explanations and clear termination criteria. These rules apply only to drug-related emergency declarations made in the past five years that are still in effect.

Longer sanctions designation period

If enacted, the bill would make a foreign opioid trafficker designation last 10 years instead of 5. That would keep sanctions in place for a longer time unless the designation is changed. The change would take effect upon enactment.

Sponsors & CoSponsors

Sponsor

Barr, Andy [R-KY-6]

KY • R

Cosponsors

  • Rep. Nunn, Zachary [R-IA-3]

    IA • R

    Sponsored 1/28/2025

  • Rep. Murphy, Gregory F. [R-NC-3]

    NC • R

    Sponsored 1/28/2025

  • Rep. Lawler, Michael [R-NY-17]

    NY • R

    Sponsored 3/10/2025

  • Rep. Moore, Tim [R-NC-14]

    NC • R

    Sponsored 3/25/2025

  • Rep. Kim, Young [R-CA-40]

    CA • R

    Sponsored 4/8/2025

  • Rep. Luna, Anna Paulina [R-FL-13]

    FL • R

    Sponsored 4/8/2025

  • Rep. Bresnahan, Robert P. [R-PA-8]

    PA • R

    Sponsored 5/5/2025

  • Rep. Pappas, Chris [D-NH-1]

    NH • D

    Sponsored 8/29/2025

  • Rep. Gillen, Laura [D-NY-4]

    NY • D

    Sponsored 9/2/2025

Roll Call Votes

All Roll Calls

Yes: 407 • No: 4

house vote • 9/2/2025

On Motion to Suspend the Rules and Pass, as Amended

Yes: 407 • No: 4

View on Congress.gov
Back to Legislation